Atrial fibrillation, or AFib is the most common type of heart arrhythmia. A new type of procedure is helping get hearts back on beat.

The US Food and Drug Administration has approved a third pulsed-field ablation system, one that can also deliver radiofrequency energy, for the treatment of atrial fibrillation (AF ... PulseSelect ...

With this approval, Medtronic is now the first and only company with two PFA technologies available for patients with Afib. The PulseSelect Pulsed Field Ablation System, which was US FDA approved in ...

Pfizer Inc. has won regulatory approval for its hympavzi drug as a treatment for hemophilia A or B without inhibitors — making it the first antitissue-factor pathway inhibitor to be allowed for ...

Affera™ Mapping and Ablation System With this approval, Medtronic is now the first and only company with two PFA technologies available for patients with Afib. The PulseSelect™ Pulsed Field Ablation ...

Medtronic has announced that the US Food and Drug Administration (FDA) has approved the Affera mapping and ablation system featuring the Sphere-9 Catheter. This innovative, all-in-one system ...

(Update: Medtronic announced FDA approval for its Affera cardiac mapping ... in paroxysmal patients,” Laske continued. “For persistent [AFib] patients, some will do PVI only and watch and wait. Others ...

With this approval, Medtronic is now the first and only company with two PFA technologies available for patients with Afib. The PulseSelect™ Pulsed Field Ablation System, which was FDA approved in ...

With this approval, Medtronic is now the first and only company with two PFA technologies available for patients with Afib. The PulseSelect Pulsed Field Ablation System, which was FDA approved in ...